Parental Education for Child Development
(CANDO Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on parental education for child development, so it's unlikely to require changes to your medications.
What data supports the effectiveness of the treatment Parental Education for Child Development?
Research shows that parenting programs can improve children's behavior and development. For example, a study found that a parenting program in Head Start centers led to better parenting practices and improved children's social skills and behavior. Another study showed that parent interventions helped improve behavior in children after a traumatic brain injury.12345
Is the Parental Education for Child Development treatment safe for children?
How does the 'Control' treatment in the Parental Education for Child Development trial differ from other treatments?
The 'Control' treatment in this trial refers to standard care or a placebo, which means it serves as a baseline to compare the effects of parental education interventions. Unlike other treatments that actively involve educational components or specialist support, the control group does not receive these additional resources, making it unique in its role as a comparison point to evaluate the effectiveness of new interventions.1112131415
What is the purpose of this trial?
The overall goal of this study is to understand how common conditions in childhood develop and if by providing specific health education and resources to parents/caregivers we can promote healthy development. This study will provide information and instruction on several aspects of infant care including, sleep, nutrition, building a healthy relationship with your baby, and healthy screen time use.
Research Team
Ruchi S Gupta, MD MPH
Principal Investigator
Northwestern University Feinberg School of Medicine
Eligibility Criteria
This trial is for parents/guardians of infants under 26 weeks old who are in good health and can give informed consent in English or Spanish. The family should be willing to follow the study's procedures, not planning to move away before the child turns one year old, and open to being randomly assigned to a group.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
The intervention group receives education about nutrition, resources, and specific instructions on promoting healthy development of their infant.
Control
The control group receives specific instructions on promoting healthy development of their infant, including guidance regarding infant sleep, screen time, and building healthy relationships.
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Control
- Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Northwestern University
Lead Sponsor
Food Allergy Research & Education
Collaborator